REVIMMUNE
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Jan 2019)
What this means for you
This application is over — abandoned 07 Jan 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86425273
- Mark type
- Stylized text
- Filed
- 16 Oct 2014
- Published for opposition
- 06 Oct 2015
- Abandoned
- 07 Jan 2019
- Attorney of record
- Christina L. Martini
Goods and services
- Class 005 — Pharmaceuticals: Biological and pharmaceutical preparations, namely, biological and pharmaceutical preparations and substances for the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disorders
- Class 042 — Scientific and technological services: Research and development of biologicals and pharmaceuticals in the prevention and treatment of blood disease and cancer, viral and other infectious diseases, and the modulation and treatment of immune system related diseases and disorders
Owner
- RevImmune, Inc., Bethesda, MD, US
- RevImmune, Inc., Bethesda, MD, US
Prosecution history
- 07 Jan 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 07 Jan 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 02 Jun 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Jun 2018 — SOU EXTENSION 5 GRANTED
- 30 May 2018 — SOU EXTENSION 5 FILED
- 30 May 2018 — SOU TEAS EXTENSION RECEIVED
- 02 Dec 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Nov 2017 — SOU EXTENSION 4 GRANTED
- 30 Nov 2017 — SOU EXTENSION 4 FILED
- 30 Nov 2017 — SOU TEAS EXTENSION RECEIVED
- 26 May 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 May 2017 — SOU EXTENSION 3 GRANTED
- 24 May 2017 — SOU EXTENSION 3 FILED
- 24 May 2017 — SOU TEAS EXTENSION RECEIVED
- 30 Nov 2016 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED